Probably 100x more expensive, with a fancy 'brand name'. Anyone with a terminal illness or chronic pain with half a brain left would simply grow the stuff.
Which is the real reason the pharmaceuticals aren't interested in investing tens of millions of dollars to research medical marijuana. NOT that the government won't let them.